Renee D Gala - Net Worth and Insider Trading
Renee D Gala Net Worth
The estimated net worth of Renee D Gala is at least $6 Million dollars as of 2024-04-28. Renee D Gala is the EVP & CFO of Jazz Pharmaceuticals PLC and owns about 35,978 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $4 Million. Renee D Gala is the SVP, CFO of Theravance Biopharma Inc and owns about 171,049 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. Renee D Gala is also the Director of Corcept Therapeutics Inc and owns about 10,000 shares of Corcept Therapeutics Inc (CORT) stock worth over $228,000. Details can be seen in Renee D Gala's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Renee D Gala has not made any transactions after 2023-05-18 and currently still holds the listed stock(s).
Transaction Summary of Renee D Gala
Renee D Gala Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Renee D Gala owns 4 companies in total, including Gossamer Bio Inc (GOSS) , Jazz Pharmaceuticals PLC (JAZZ) , and Theravance Biopharma Inc (TBPH) among others .
Click here to see the complete history of Renee D Gala’s form 4 insider trades.
Insider Ownership Summary of Renee D Gala
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GOSS | Gossamer Bio Inc | 2019-02-07 | director |
JAZZ | Jazz Pharmaceuticals PLC | 2023-05-18 | EVP & CFO |
TBPH | Theravance Biopharma Inc | 2018-08-15 | VP-Finance |
CORT | Corcept Therapeutics Inc | 2018-03-07 | director |
Renee D Gala Latest Holdings Summary
Renee D Gala currently owns a total of 3 stocks. Among these stocks, Renee D Gala owns 35,978 shares of Jazz Pharmaceuticals PLC (JAZZ) as of May 18, 2023, with a value of $4 Million and a weighting of 68.78%. Renee D Gala owns 171,049 shares of Theravance Biopharma Inc (TBPH) as of August 15, 2018, with a value of $2 Million and a weighting of 27.24%. Renee D Gala also owns 10,000 shares of Corcept Therapeutics Inc (CORT) as of March 7, 2018, with a value of $228,000 and a weighting of 3.98%.
Latest Holdings of Renee D Gala
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
JAZZ | Jazz Pharmaceuticals PLC | 2023-05-18 | 35,978 | 109.46 | 3,938,152 |
TBPH | Theravance Biopharma Inc | 2018-08-15 | 171,049 | 9.12 | 1,559,967 |
CORT | Corcept Therapeutics Inc | 2018-03-07 | 10,000 | 22.80 | 228,000 |
Holding Weightings of Renee D Gala
Renee D Gala Form 4 Trading Tracker
According to the SEC Form 4 filings, Renee D Gala has made a total of 2 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 6,000 shares on May 18, 2023, which brought Renee D Gala around $790,500.
According to the SEC Form 4 filings, Renee D Gala has made a total of 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. The most-recent trade in Theravance Biopharma Inc is the sale of 43,743 shares on August 15, 2018, which brought Renee D Gala around $1 Million.
According to the SEC Form 4 filings, Renee D Gala has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the acquisition of 10,000 shares on March 7, 2018, which cost Renee D Gala around $155,100.
Insider Trading History of Renee D Gala
- 1
Renee D Gala Trading Performance
GuruFocus tracks the stock performance after each of Renee D Gala's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Renee D Gala is 27.75%. GuruFocus also compares Renee D Gala's trading performance to market benchmark return within the same time period. The performance of stocks bought by Renee D Gala within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Renee D Gala's insider trading performs compared to the benchmark.
Performance of Renee D Gala
Average Return
54.36%
Outperforming Transactions
50%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 9.28 | 27.75 | 13.57 | 54.36 | 18.43 | 23.44 |
Relative Return to S&P 500(%) | 14.19 | 28.19 | 15.09 | 52.07 | 12.47 | 12.05 |
Renee D Gala Ownership Network
Ownership Network List of Renee D Gala
Ownership Network Relation of Renee D Gala
Renee D Gala Owned Company Details
What does Gossamer Bio Inc do?
Who are the key executives at Gossamer Bio Inc?
Renee D Gala is the director of Gossamer Bio Inc. Other key executives at Gossamer Bio Inc include EVP & General Counsel Waage Christian , Chief Financial Officer Bryan Giraudo , and director & Executive Chairman Faheem Hasnain .
Gossamer Bio Inc (GOSS) Insider Trades Summary
Over the past 18 months, Renee D Gala made no insider transaction in Gossamer Bio Inc (GOSS). Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 298,570 shares made by Bryan Giraudo , a net sale of 13,395 shares made by Richard Aranda , and a net purchase of 855,400 shares made by Faheem Hasnain .
In summary, during the past 3 months, insiders sold 44,068 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 44,068 shares. During the past 18 months, 67,038 shares of Gossamer Bio Inc (GOSS) were sold and 1,234,072 shares were bought by its insiders, resulting in a net purchase of 1,167,034 shares.
Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gossamer Bio Inc Insider Transactions
Renee D Gala Mailing Address
Above is the net worth, insider trading, and ownership report for Renee D Gala. You might contact Renee D Gala via mailing address: 901 Gateway Blvd, South San Francisco Ca 94080.